Briacell Therapeutics Corp Share Price Toronto S.E.
Equities
CA10778Y1043
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.16Cr 2.96Cr 180.44Cr |
---|---|---|---|---|---|
Net income 2024 * | -2.4Cr -3.29Cr -200.49Cr | Net income 2025 * | -3.6Cr -4.93Cr -300.73Cr | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-1.18
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 84.44% |
Managers | Title | Age | Since |
---|---|---|---|
William Williams
CEO | Chief Executive Officer | 68 | 01/16/01 |
Gadi Levin
DFI | Director of Finance/CFO | 52 | 01/16/01 |
Chief Tech/Sci/R&D Officer | 53 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Schmieg
BRD | Director/Board Member | 62 | 10/16/10 |
Marc Lustig
BRD | Director/Board Member | 51 | 31/21/31 |
Rebecca Taub
BRD | Director/Board Member | 71 | 07/18/07 |
1st Jan change | Capi. | |
---|---|---|
+15.19% | 12TCr | |
+19.91% | 11TCr | |
+8.24% | 2.36TCr | |
-19.80% | 2.04TCr | |
-16.19% | 1.65TCr | |
-13.45% | 1.64TCr | |
-44.35% | 1.56TCr | |
+66.67% | 1.52TCr | |
+2.13% | 1.35TCr |